Method of defining a biological target for treatment

Details Method of defining a biological target for treatment Method of defining a biological target for treatment

2006-05-03

2010-11-09

Casler, Brian (Department: 3737)

Surgery

Diagnostic testing

Detecting nuclear, electromagnetic, or ultrasonic radiation

C600S407000, C600S414000, C600S415000, C600S426000, C600S429000, C606S130000

Reexamination Certificate

active

07831293

ABSTRACT:
A method of defining a biological target for treatment in which image detectable markers are placed at and correlated to the location or locations of tissue biopsy. By obtaining pathological analysis of the biopsy tissue specimens and correlating the analysis to the corresponding marker locations, the definitive pathological analysis of the target tissue at the marker locations can be correlated to corresponding locations on a functional image of the target tissue. The correlation of the marker locations and pathology to the corresponding locations on a functional image can then be used to prescribe and apply modulated therapy to the target tissue.

REFERENCES:
patent: 4460559 (1984-07-01), Goldenberg
patent: 5682890 (1997-11-01), Kormos et al.
patent: 5891034 (1999-04-01), Bucholz
patent: 6056700 (2000-05-01), Burney et al.
patent: 6173175 (2001-01-01), Alazma et al.
patent: 6173201 (2001-01-01), Front
patent: 6347240 (2002-02-01), Foley et al.
patent: 6350244 (2002-02-01), Fisher
patent: 6368331 (2002-04-01), Front et al.
patent: 6560354 (2003-05-01), Maurer, Jr. et al.
patent: 6567687 (2003-05-01), Front et al.
patent: 6725080 (2004-04-01), Melkent et al.
patent: 6824516 (2004-11-01), Batten et al.
patent: 6826422 (2004-11-01), Modell et al.
patent: 7001341 (2006-02-01), Gellman et al.
patent: 7162292 (2007-01-01), Ohno et al.
patent: 7379769 (2008-05-01), Piron et al.
patent: 2002/0026127 (2002-02-01), Balbierz et al.
patent: 2002/0107437 (2002-08-01), Sirimanne et al.
patent: 2002/0146371 (2002-10-01), Li et al.
patent: 2004/0106869 (2004-06-01), Tepper
patent: 2004/0133101 (2004-07-01), Mate et al.
patent: 2005/0035296 (2005-02-01), Kojima et al.
patent: 2005/0038355 (2005-02-01), Gellman et al.
patent: 2005/0053607 (2005-03-01), Bates et al.
patent: 2005/0080333 (2005-04-01), Piron et al.
patent: 2005/0159676 (2005-07-01), Taylor et al.
patent: 2006/0258933 (2006-11-01), Ellis et al.
patent: 2007/0016014 (2007-01-01), Hara et al.
patent: 2008/0221439 (2008-09-01), Iddan et al.
patent: 2008/0221440 (2008-09-01), Iddan et al.
patent: 1506742 (2005-02-01), None
John E. Sylvester, M.D., et al., “Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience”, Int. J. Radiation Oncology Biol. Phys., vol. 57, No. 4, pp. 944-952, 2003.
Winston E. Barzell, M.D., et al., “How to perform transperineal saturation prostate biopsy”, Urology Times, http://ut.adv100.com/urologytimes/contect/printContentPopup.jsp?id+56612, printed Feb. 11, 2004.
George L. Wright, Jr., PhD., et al., “Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues”, Urol Oncol 1995; 1:18-28.
Rodney J. Ellis, M.D., et al., “Radioimmunoguided imaging of prostate cancer foci with histopathological correlation”, Int. J. Radiation Oncology Biol. Phys., vol. 49, No. 5, pp. 1281-1286, 2001.
Rodney J. Ellis, M.D., et al., “Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma”, Int. J. Radiation Oncology Biol. Phys., vol. 57, No. 2, pp. 362-370, 2003.
Gordon L. Grado, M.D., et al., “Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance”, Int. J. Radiation Oncology Biol. Phys., vol. 42, No. 2, pp. 289-298, 1998.
Michael J. Zelefsky, M.D., et al., “Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 41, No. 3, pp. 491-500, 1998.
D. Bruce Sodee, et al., “Prostate cancer and prostate bed SPECT imaging with ProstaScint®: semiquantitative correlation with prostatic biopsy results”, The Prostate 37:140-148, 1998.
Jean M. Moran, et al., “Radiotherapy: what can be achieved by technical improvements in dose delivery?”, Lancet Oncol 2005; vol. 6, pp. 51-58, Jan. 2005.
Mehraj Sheikh,M.D., et al., “Patients' tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients”, Journal of Clinical Ultrasound, vol. 33, No. 9, pp. 452-456, Dec. 2005.
Yan Yu, et al., “Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64a)”, Med. Phys. 26(10), pp. 2054-2076, Oct. 1999.
Juanita M. Crook, et al., “Critical organ dosimetry in permanent seed prostate brachtherapy: defining the organs at risk”, Brachytherapy 4 (2005), pp. 186-194.
Chiaho Hua, Ph.D., et al., “Development of a semi-automatic alignment tool for accelerated localization of the prostate”, Int. J. Radiation Oncology Biol. Phys., vol. 55, No. 3, pp. 811-824, 2003.
Zhenghong Lee, et al., “Multimodal and three-dimensional imaging of prostate cancer”, Computerized Medical Imaging and Graphics 29 (2005), pp. 477-486.
Emile N.J.T. van Lin, M.D., et al., “IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and1H-spectroscopic MRI”, Int. J. Radiation Oncology Biol. Phys., vol. 65, No. 1, pp. 291-303, 2006.
Gregory S. Merrick, M.D., et al., “Erectile function after prostate brachytherapy”, Int. J. Radiation Oncology Biol. Phys., vol. 62, No. 2, pp. 437-447, 2005.
Daphna Y. Gelblum, M.D., et al., “Rectal complications associated with transperineal interstitial brachtherapy for prostate cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 48, No. 119-124, 2000.
Kenneth Hu, M.D., et al., “Clinical course of rectal bleeding following I-125 prostate brachytherapy”, Int. J. Radiation Oncology Biol. Phys., vol. 41, No. 2, pp. 263-265, 1998.
Jean Pouliot, Ph.D., et al., “(Non)-Migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device”, Int. J. Radiation Oncology Biol. Phys., vol. 56, No. 3, pp. 862-866, 2003.
Peter D. Grimm, et al., “Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique”, Brachtherapy 3 (2004), pp. 34-40.
Rodney, J. Ellis, et al., “Translation of SPECT/CT Guided Prostate Brachytherapy to a community setting from the university setting with a case example of histopathologic correlation to the image set”, Society of Nuclear Medicine 52nd Annual Meeting Poster 1423; J Nucl Med Suppl 2005; 24(2):439 (abstract).
Eclipse™ Integrated Treatment Planning, Brachytherapy, Varian Medical Systems, Oncology Systems, RAD 7154, Oct. 2002 (300).
Eclipse™ Integrated Treatment Planning, Plan Evaluation, Varian Medical Systems, Oncology Systems, RAD 7159, Oct. 2003 (6M).
Robert C. Susil, et al., “System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner”, Magnetic Resonance in Medicine, vol. 52, Issue 3, pp. 683-687, published online Aug. 23, 2004 (abstract).
Frauscher, F., et al., “Comparison of contract enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact of prostate cancer detection”, J. Urol. Apr. 2002; 167(4): 1648-52 (abstract).
Leonard R. Coover, et al, “Breast tumor localization using sestamibi.”, Clinical Nuclear Medicine, Vo. 27, No. 3, pp. 161-164.
Welsh JS, et al., “Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy”, Technol. Cancer Re. Treat. 2004; 3:359-64 (abstract).
Deborah Rhodes, et al., “Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast”, May Clinic Proceedings, Jan. 2005, vol. 80, Issue 1, pp. 24-30 (abstract).
Leonard R. Coover, MD, et al., “Scintimammography with dedicated breast ca

Affiliated with

Also associated with

Rating

Method of defining a biological target for treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of defining a biological target for treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of defining a biological target for treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4208072